135 related articles for article (PubMed ID: 10745096)
1. NB-506, an indolocarbazole topoisomerase I inhibitor, binds preferentially to triplex DNA.
Ren J; Bailly C; Chaires JB
FEBS Lett; 2000 Mar; 470(3):355-9. PubMed ID: 10745096
[TBL] [Abstract][Full Text] [Related]
2. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
3. Sequence and structural selectivity of nucleic acid binding ligands.
Ren J; Chaires JB
Biochemistry; 1999 Dec; 38(49):16067-75. PubMed ID: 10587429
[TBL] [Abstract][Full Text] [Related]
4. A DNA binding indolocarbazole disaccharide derivative remains highly cytotoxic without inhibiting topoisomerase I.
Qu X; Chaires JB; Ohkubo M; Yoshinari T; Nishimura S; Bailly C
Anticancer Drug Des; 1999 Oct; 14(5):433-42. PubMed ID: 10766298
[TBL] [Abstract][Full Text] [Related]
5. Tight binding of the antitumor drug ditercalinium to quadruplex DNA.
Carrasco C; Rosu F; Gabelica V; Houssier C; De Pauw E; Garbay-Jaureguiberry C; Roques B; Wilson WD; Chaires JB; Waring MJ; Bailly C
Chembiochem; 2002 Dec; 3(12):1235-41. PubMed ID: 12465032
[TBL] [Abstract][Full Text] [Related]
6. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.
Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T
Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146
[TBL] [Abstract][Full Text] [Related]
7. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
[TBL] [Abstract][Full Text] [Related]
8. Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin.
Bailly C; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M; Waring MJ
Mol Pharmacol; 1998 Jan; 53(1):77-87. PubMed ID: 9443934
[TBL] [Abstract][Full Text] [Related]
9. Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue.
Bailly C; Qu X; Anizon F; Prudhomme M; Riou JF; Chaires JB
Mol Pharmacol; 1999 Feb; 55(2):377-85. PubMed ID: 9927631
[TBL] [Abstract][Full Text] [Related]
10. Triple helix-forming oligonucleotides conjugated to indolocarbazole poisons direct topoisomerase I-mediated DNA cleavage to a specific site.
Arimondo PB; Bailly C; Boutorine AS; Moreau P; Prudhomme M; Sun JS; Garestier T; Hélène C
Bioconjug Chem; 2001; 12(4):501-9. PubMed ID: 11459453
[TBL] [Abstract][Full Text] [Related]
11. Indolocarbazole glycosides in inactive conformations.
Facompré M; Carrasco C; Vezin H; Chisholm JD; Yoburn JC; Van Vranken DL; Bailly C
Chembiochem; 2003 May; 4(5):386-95. PubMed ID: 12740810
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence polarization studies of the binding of BMS 181176 to DNA.
Krishnan BS; Moore ME; Lavoie CP; Long BH; Dalterio RA; Wong HS; Rosenberg IE
J Biomol Struct Dyn; 1994 Dec; 12(3):625-36. PubMed ID: 7727062
[TBL] [Abstract][Full Text] [Related]
13. Probing the recognition surface of a DNA triplex: binding studies with intercalator-neomycin conjugates.
Xue L; Xi H; Kumar S; Gray D; Davis E; Hamilton P; Skriba M; Arya DP
Biochemistry; 2010 Jul; 49(26):5540-52. PubMed ID: 20499878
[TBL] [Abstract][Full Text] [Related]
14. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.
Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y
Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241
[TBL] [Abstract][Full Text] [Related]
15. Berenil [1,3-bis(4'-amidinophenyl)triazene] binding to DNA duplexes and to a RNA duplex: evidence for both intercalative and minor groove binding properties.
Pilch DS; Kirolos MA; Liu X; Plum GE; Breslauer KJ
Biochemistry; 1995 Aug; 34(31):9962-76. PubMed ID: 7632695
[TBL] [Abstract][Full Text] [Related]
16. Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110.
Yoshinari T; Yamada A; Uemura D; Nomura K; Arakawa H; Kojiri K; Yoshida E; Suda H; Okura A
Cancer Res; 1993 Feb; 53(3):490-4. PubMed ID: 8381047
[TBL] [Abstract][Full Text] [Related]
17. The binding of analogues of coralyne and related heterocyclics to DNA triplexes.
Latimer LJ; Payton N; Forsyth G; Lee JS
Biochem Cell Biol; 1995; 73(1-2):11-8. PubMed ID: 7662309
[TBL] [Abstract][Full Text] [Related]
18. Energetics of strand-displacement reactions in triple helices: a spectroscopic study.
Mills M; Arimondo PB; Lacroix L; Garestier T; Hélène C; Klump H; Mergny JL
J Mol Biol; 1999 Sep; 291(5):1035-54. PubMed ID: 10518941
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamics of nucleic acid "shape readout" by an aminosugar.
Xi H; Davis E; Ranjan N; Xue L; Hyde-Volpe D; Arya DP
Biochemistry; 2011 Oct; 50(42):9088-113. PubMed ID: 21863895
[TBL] [Abstract][Full Text] [Related]
20. Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11- dihydroxy-13-(beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4- c]carbazole-5,7(6H)-dione (NB-506): induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity.
Yoshinari T; Matsumoto M; Arakawa H; Okada H; Noguchi K; Suda H; Okura A; Nishimura S
Cancer Res; 1995 Mar; 55(6):1310-5. PubMed ID: 7882328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
